AzTrials
AzTrials

Airway Management AssessmentNCT07027293

The Insertion of I-gel and Classic LMA in Different Head Positions in Elderly Patients

A study testing STANDART HEAD POSITION, HEAD ROTATION POSITION and Classic laryngeal mask airway (LMA) in people with Airway Management Assessment and Supraglottic Airways, run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective, randomized, double-blind clinical study aims to evaluate the insertion success of two supraglottic airway devices, the classic Laryngeal Mask Airway (LMA) and the I-gel, in different head and neck positions in elderly patients undergoing elective urological surgery under general anesthesia. Read more about this study

Who is it for?
Ages 75 years and older
What is being tested?
STANDART HEAD POSITION, HEAD ROTATION POSITION and Classic laryngeal mask airway (LMA)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Jun 2025to 15 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • ASA classification I-III
  • Age over 75 years

Who cannot join

  • Known or anticipated difficult airway
  • Contraindications for the use of a supraglottic airway device
  • Patients scheduled for endotracheal intubation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Yadigar Yılmaz

    Istanbul, 34230

    Yadigar Yılmaz, 5053069924, dryadigaryilmaz@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Insertion of I-gel and Classic LMA in Different Head Positions in Elderly Patients

This prospective, randomized, double-blind clinical study aims to evaluate the insertion success of two supraglottic airway devices, the classic Laryngeal Mask Airway (LMA) and the I-gel, in different head and neck positions in elderly patients undergoing elective urological surgery under general anesthesia. A total of 120 patients aged over 75 years with ASA physical status I-III will be randomly assigned to one of four groups: standard position with I-gel, right lateral rotation with I-gel, standard position with classic LMA, and right lateral rotation with classic LMA. The study will compare insertion time, ease and success of placement, number of attempts, hemodynamic responses, oropharyngeal leak pressures, fiberoptic scores, and airway-related complications. The findings aim to provide clinical guidance on the optimal use of supraglottic airway devices in geriatric patients in various head positions.

Being tested
STANDART HEAD POSITION, HEAD ROTATION POSITION, Classic laryngeal mask airway (LMA), i-gel supraglottic airway device
Keywords
Supraglottic airway device, i-gel, Classic laryngeal mask airway, Elderly patients, Airway management, Head position, General anesthesia, Insertion success

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • STANDART HEAD POSITIONOther

    STANDART HEAD POSITION

  • HEAD ROTATION POSITIONOther

    HEAD ROTATION POSITION

  • Classic laryngeal mask airway (LMA)Device

    Classic laryngeal mask airway (LMA)

  • i-gel supraglottic airway deviceDevice

    i-gel supraglottic airway device

Study groups in NCT07027293
Study groupRoleWhat they receive
Standard head position + i-gelActive comparatorNot described
Receives: Other: STANDART HEAD POSITION; Device: i-gel supraglottic airway device
Rotated head position + i-gelActive comparatorNot described
Receives: Other: HEAD ROTATION POSITION; Device: i-gel supraglottic airway device
Standard head position + classic LMAActive comparatorNot described
Receives: Other: STANDART HEAD POSITION; Device: Classic laryngeal mask airway (LMA)
Rotated head position + classic LMAActive comparatorNot described
Receives: Other: HEAD ROTATION POSITION; Device: Classic laryngeal mask airway (LMA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insertion Time of Supraglottic Airway Device

    Measured: 1-10 minutes

  2. Number of attempts for LMA replacement

    Measured: 15-200 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2025
  2. Study start20 Jun 2025
  3. Primary completion15 Sep 2025 (estimated)
  4. Study completion15 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07027293
Sponsor's protocol ID
E-10840098-202.3.02-1265
Status last verified
Sep 2025
First submitted
27 May 2025
Last updated
17 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing STANDART HEAD POSITION, HEAD ROTATION POSITION and Classic laryngeal mask airway (LMA) in people with Airway Management Assessment and Supraglottic Airways, run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insertion Time of Supraglottic Airway Device (time frame: 1-10 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in